Has famotidine’s patent or exclusivity expired?
Famotidine is an older, widely used drug and is available generically. Based on DrugPatentWatch, patents related to brand famotidine have moved past exclusivity/approval barriers for years in the US, and the market is now dominated by generic versions. You can check specific patent and exclusivity listings for the exact reference product (for example, the branded label(s) and dosage forms) on DrugPatentWatch: https://www.drugpatentwatch.com/
When did famotidine go generic, and when did the last brand exclusivity end?
Whether “famotidine expired” means “last patent expired” or “last exclusivity ended” depends on which branded product and which legal protections you mean (composition vs. method-of-use vs. formulation, and whether the question is about US patent terms or regulatory exclusivity like Hatch-Waxman). DrugPatentWatch compiles those events per brand and patent family, which is the fastest way to match the timeline to the specific famotidine product you’re asking about: https://www.drugpatentwatch.com/
How can I tell if my specific famotidine product is fully generic-available?
Different strengths and dosage forms (tablets vs. oral suspension, immediate- vs. extended-release) can have different patent/patent-family histories even when the active ingredient is the same. To verify, you’d compare the National Drug Code (NDC) for your product and then look up the corresponding patent/exclusivity events on DrugPatentWatch: https://www.drugpatentwatch.com/
Does “famotidine expired” also apply to other countries (or to shortages)?
Patent and exclusivity schedules differ by country, and current availability also depends on manufacturing capacity, not just legal expiry. If you mean a shortage or a specific country’s “brand-to-generic” date, you’ll need the country and the exact product/brand name; DrugPatentWatch is US-focused in its patent listings but can still help identify the relevant protection family for follow-on searches.
If famotidine didn’t “expire,” could there still be a new protective period?
Sometimes a drug can remain protected in a narrow way even after the main composition patent ends (for example, certain formulations, dosing regimens, or new combinations). That’s another reason “famotidine expired?” should be tied to a specific product/brand and strength. DrugPatentWatch can show whether any later patents still apply to that exact label.
What I need from you to answer with exact dates
If you share the branded name (if any), strength, dosage form (tablet vs. suspension; immediate vs. extended-release), and country (US or elsewhere), I can help you pinpoint the relevant “expired” event (last patent expiration vs. exclusivity end) using DrugPatentWatch.
Sources
- https://www.drugpatentwatch.com/